RELB anticorps (AA 248-492)
Aperçu rapide pour RELB anticorps (AA 248-492) (ABIN7629444)
Antigène
Voir toutes RELB AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 248-492
-
Fonction
- V-Rel Reticuloendotheliosis Viral Oncogene Homolog B (RELB) Polyclonal Antibody
-
Séquence
- Asp248~Asp492
-
Attributs du produit
- The V-Rel Reticuloendotheliosis Viral Oncogene Homolog B (RELB) Polyclonal Antibody (Species: Human) has been validated for the following applications: WB, IHC, ICC, IP.
-
Purification
- Antigen-specific affinity chromatography followed by Protein A affinity chromatography
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.5 mg/mL
-
Buffer
- 0.01M PBS, pH 7.4, containing 0.05 % Proclin-300, 50 % glycerol
-
Agent conservateur
- ProClin
-
Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- 2°C to 8°C for frequent use, -20°C for 12 months. Avoid repeated freeze/thaw cycles.
-
Date de péremption
- 12 months
-
-
- RELB (V-Rel Reticuloendotheliosis Viral Oncogene Homolog B (RELB))
-
Autre désignation
- RELB
-
ID gène
- 5971
-
UniProt
- Q01201
-
Pathways
- Signalisation NF-kappaB, Signalisation RTK
Antigène
-